Chevy Chase Trust Holdings, Inc. Xeris Biopharma Holdings, Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q3 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 51,243 shares of XERS stock, worth $172,688. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,243
Previous 51,243
-0.0%
Holding current value
$172,688
Previous $115,000
26.96%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
142Shares Held
59.9MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$34.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$26.2 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$17.2 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$11.7 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$11.2 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $458M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...